About Leon Chen
Leon Chen is a director at Eikon Therapeutics.
Leon Chen reports to the SEC as a director of 3 public companies, including LogicBio Therapeutics (LOGC) and Nurix Therapeutics (NRIX).
Leon Chen first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Leon Chen in the role, so the role may have started earlier or lasted longer.
LI
LogicBio Therapeutics, Inc.
Director
2018 – 2022 · Public company (LOGC)
NI
Nurix Therapeutics, Inc.
Director
2020 – 2021 · Public company (NRIX)
Key Colleagues at Startups
The people Leon Chen works with at each company, as listed on that company's latest Form D.
Eikon Therapeutics, Inc. · Form D, Feb 28, 2025
RH
Robbie Huffines
Director
JW
Joshua Wolfe
Director
DB
Dror Berman
Director
JT
James Tananbaum
Director
KF
Kenneth Frazier
Director
RW
Robin Washington
Director
RP
Roger Perlmutter
CEO and director